159 related articles for article (PubMed ID: 9256917)
1. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
3. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
Basarab T; Orchard G; Russell-Jones R
Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
[TBL] [Abstract][Full Text] [Related]
4. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Basal Cell Carcinoma and Trichoepithelioma: An Immunohistochemical Study.
Carrasquillo OY; Cruzval-O'Reilly E; Sánchez JE; Valentín-Nogueras SM
Am J Dermatopathol; 2021 Mar; 43(3):191-197. PubMed ID: 32809979
[TBL] [Abstract][Full Text] [Related]
6. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
Poniecka AW; Alexis JB
Am J Dermatopathol; 1999 Aug; 21(4):332-6. PubMed ID: 10446773
[TBL] [Abstract][Full Text] [Related]
8. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
10. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
Kirchmann TT; Prieto VG; Smoller BR
Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
[TBL] [Abstract][Full Text] [Related]
11. Trichoepithelioma: a 19-year clinicopathologic re-evaluation.
Bettencourt MS; Prieto VG; Shea CR
J Cutan Pathol; 1999 Sep; 26(8):398-404. PubMed ID: 10551412
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens.
Mostafa NA; Assaf M; Elhakim S; Abdel-Halim MRE; El-Nabarawy E; Gharib K
J Cutan Pathol; 2018 Nov; 45(11):807-816. PubMed ID: 29917261
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
[TBL] [Abstract][Full Text] [Related]
16. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.
Ionescu DN; Arida M; Jukic DM
Arch Pathol Lab Med; 2006 Jan; 130(1):45-51. PubMed ID: 16390237
[TBL] [Abstract][Full Text] [Related]
17. Immunostaining for CD34 to determine trichoepithelioma.
Bryant D; Penneys NS
Arch Dermatol; 1995 May; 131(5):616-7. PubMed ID: 7537953
[No Abstract] [Full Text] [Related]
18. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
[TBL] [Abstract][Full Text] [Related]
19. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta distribution in basal cell carcinomas: relationship to proliferation index.
Stamp GW; Nasim M; Cardillo M; Sudhindra SG; Lalani EN; Pignatelli M
Br J Dermatol; 1993 Jul; 129(1):57-64. PubMed ID: 8103666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
